Showing 1 - 16 results of 16 for search 'Anna Linda Zignego', query time: 0.20s Refine Results
  1. 1
    The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis
    by Serena Lorini, Laura Gragnani, Anna Linda Zignego
    Published 2020-11-01
    Get full text
    Article
  2. 2
    HCV and Lymphoproliferation
    Get full text
    Article
  3. 3
    Role of Notch Receptors in Hematologic Malignancies
    Get full text
    Article
  4. 4
    Treatment or Prophylaxis against Hepatitis B Virus Infection in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: An Update
    Get full text
    Article
  5. 5
    Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
    Get full text
    Article
  6. 6
    Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition.
    Get full text
    Article
  7. 7
    Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
    Get full text
    Article
  8. 8
    Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)
    Get full text
    Article
  9. 9
    Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
    Get full text
    Article
  10. 10
    Individualized treatment of genotype 1 naïve patients: an Italian multicenter field practice experience.
    Get full text
    Article
  11. 11
    Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
    Get full text
    Article
  12. 12
    Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.
    Get full text
    Article
  13. 13
    Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
    Get full text
    Article
  14. 14
    Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    Get full text
    Article
  15. 15
    Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    Get full text
    Article
  16. 16
    Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
    by Loreta A Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, Alfredo Di Leo, Andrea Iannone, Teresa Antonia Santantonio, Adele Giammario, Giovanni Raimondo, Roberto Filomia, Carmine Coppola, Daniela Caterina Amoruso, Pierluigi Blanc, Barbara Del Pin, Liliana Chemello, Luisa Cavalletto, Filomena Morisco, Laura Donnarumma, Maria Grazia Rumi, Antonio Gasbarrini, Massimo Siciliano, Marco Massari, Romina Corsini, Barbara Coco, Salvatore Madonia, Marco Cannizzaro, Anna Linda Zignego, Monica Monti, Francesco Paolo Russo, Alberto Zanetto, Marcello Persico, Mario Masarone, Erica Villa, Veronica Bernabucci, Gloria Taliani, Elisa Biliotti, Luchino Chessa, Maria Cristina Pasetto, Pietro Andreone, Marzia Margotti, Giuseppina Brancaccio, Donatella Ieluzzi, Guglielmo Borgia, Emanuela Zappulo, Vincenza Calvaruso, Salvatore Petta, Loredana Falzano, Maria Giovanna Quaranta, Liliana Elena Weimer, Stefano Rosato, Stefano Vella, Edoardo Giovanni Giannini
    Published 2017-01-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search